PGY-2 Oncology Pharmacy Residency

The PGY-2 Oncology Pharmacy Residency at Cedars-Sinai is designed to provide the resident with extensive training in the treatments of cancer, hematological conditions, and complications related to chemotherapy. Comprehensive cancer care is provided through two outpatient cancer programs and inpatient adult and pediatric programs. Pharmacists’ services are integrated within the bone marrow transplant team and investigational drug research programs. The program is in precandidate status by the American Society of Health-System Pharmacists (ASHP) with anticipated accreditation. Once accreditation is achieved, all previous residents will be considered to have completed an ASHP-accredited PGY2 residency.